The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Vol.
32
No.
12
December 25, 2009Dec 25, 2009
Free
DOWNLOAD THE PDF

ASCO Annual Report Names Significant Clinical Research Advances Of Past Year

Revlimid Extends Time To Progression Compared To Placebo In Phase III Trial

Tykerb Plus Herceptin Better Than Monotherapy, Study Says

Bisphosphonates May Reduce Recurrent Breast Cancer

Study Finds High-Risk Women Reluctant To Take Tamoxifen

Cervical Cancer Screening Can Be Done Later, Less Often

No Benefit For Cetuximab In Early-Stage Colon Cancer

NCI Cooperative Group Clinical Trials Approved

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login

Site license subscribers:
Log in with your IP | Register a sponsored account